MAP
KURA icon

Moody Aldrich Partners’s Kura Oncology KURA Stock Holding History

Moody Aldrich Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-179,728
Closed -$1.87M – 202
2025
Q4 		$1.87M Buy
+179,728
New +$1.89M 0.35% 112
2025
Q1 		– Sell
-143,587
Closed -$1.25M – 193
2024
Q4 		$1.25M Buy
143,587
+42,712
+42% +$615K 0.23% 109
2024
Q3 		$1.97M Sell
100,875
-2,042
-2% -$41.4K 0.36% 102
2024
Q2 		$2.12M Sell
102,917
-6,934
-6% -$143K 0.41% 90
2024
Q1 		$2.34M Buy
+109,851
New +$2.14M 0.4% 89

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moody Aldrich Partners's KURA Position: Q1 2026 in Review

Moody Aldrich Partners sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 179,728 shares — an estimated $1.87M sold.

Moody Aldrich Partners first reported a position in KURA in Q1 2024 and held it in 5 quarters. The position peaked at $2.34M in Q1 2024. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Moody Aldrich Partners reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Moody Aldrich Partners sold 179,728 Kura Oncology shares in Q1 2026, an estimated $1.87M.
  • Moody Aldrich Partners first reported a position in Kura Oncology in Q1 2024 and held it in 5 quarters.
  • Moody Aldrich Partners's Kura Oncology position peaked at $2.34M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Moody Aldrich Partners's 13F filing for Q1 2026, filed 20 Apr 2026.